Viewing Study NCT05661357


Ignite Creation Date: 2025-12-24 @ 7:01 PM
Ignite Modification Date: 2025-12-29 @ 11:07 PM
Study NCT ID: NCT05661357
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-17
First Post: 2022-11-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Disitamab Vedotin Combined With Fruquintinib for mCRC With HER2 Expression
Sponsor: Zhongnan Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module